1. P01.01 A Phase 1a/1b dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors. (1st October 2020) Authors: ABBAS, A; Strauss, J; Janku, F; Karim, R; Olszanski, A; Luke, JJ; Leach, K; Iyer, R Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗